Celine Bio is pioneering a patient-first tech-bio platform that integrates large-scale patient data, proteomics, and metabolic reprogramming method with the power of Generative AI to decode actionable insights and rejuvenate immune cells. Our mission is to accelerate access to life-saving medicines, maximize clinical success, and transform patient outcomes. Our proprietary platform has been validated across multiple diseases, which demonstrated the potential to drive meaningful impact for patients with unmet needs.
What is the problem?
90% of U.S. healthcare spending is directed toward age-related diseases, over $3 trillion. Immune aging is a critical risk factor for most complex age-related diseases. Effectively treating these diseases requires a multi-dimensional, personalized approach that comprehensively maps the disease ecosystem while embracing patient diversity and genetic variability. Traditional methods often focus on a single element, failing to address the true complexity and mechanisms of the disease as interconnected wholes. These approaches are slow, costly, and not effective, with over 70% of clinical trials failing and benefiting only about 1.5% of patients with complex age-related diseases.
What is their solution?
At Celine Bio, we take a holistic, multi-dimensional approach to personalized medicine, understanding that treatment efficacy is influenced by a variety of factors. Our patient-first tech-bio platform seamlessly integrates our proprietary large-scale patient-derived data, Generative AI, and novel methods to decode actionable patient-level insights. This enables three key capabilities: 1-Predict diagnostics and prognostics for better clinical trial designs. 2- Design precision medicine to reset immune cells. 3- Determine patient response and predict translatability. Our proprietary platform has been validated across multiple disease areas (in vitro, in vivo), which demonstrated its potential to drive meaningful outcomes for patients with unmet medical needs. We are on a mission to accelerate access to life-saving medicines, maximize clinical success, and transform patient outcomes. We envision a world with longer, healthier lives that are accessible to all.
.svg)
